Expanded Access for CC-486
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-486.
Acute Myelogenous Leukemia (AML)
DRUG: CC-486
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-486.